{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Risk of Breast Implant-Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL)
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information about breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), including the details of a study tracking the outcomes of a large cohort of patients undergoing breast reconstruction.Learning Objectives
After completing this continuing education activity you will be able to:
- Define BIA-ALCL, including risk factors and characteristics.
- Describe the methodology and outcomes of a prospective, cohort study of patients undergoing breast reconstruction.
Disclosures
The author and planners have disclosed no potential conflicts of interest, financial or otherwise.
Price:
$12.95
Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: PSN1020E
Published: Oct/Dec 2020
Expires: 12/6/2024
Sources:
Plastic and Aesthetic Nursing
Required Passing Score: 7/9 (77%)